BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
2 | 435.00 | 438.00 | 261 |
500 | 432.55 | 438.50 | 26 |
150 | 432.50 | 438.75 | 10 |
1 | 432.00 | 438.85 | 100 |
2 | 430.00 | 439.25 | 19 |
6482 | Total | Total | 25460 |
As on 25 Jan, 2023 | 04:01
BUY | SELL | ||
---|---|---|---|
QTY | PRICE | PRICE | QTY |
2 | 435.00 | 438.00 | 261 |
500 | 432.55 | 438.50 | 26 |
150 | 432.50 | 438.75 | 10 |
1 | 432.00 | 438.85 | 100 |
2 | 430.00 | 439.25 | 19 |
6482 | Total | Total | 25460 |
Stock with good financial performance alongside good to expensive valuation
Open | 434.60 |
Previous Close | 434.60 |
Volume | 2,211,079.00 |
Value (Lacs) | 9,687.84 |
VWAP | 429.81 |
Beta |
High | 440.80 |
Low | 425.05 |
UC Limit | 521.50 |
LC Limit | 347.70 |
52 Week High | 482.80 |
52 Week Low | 326.15 |
TTM EPS See historical trend | 9.72 (+107.91% YoY) |
TTM PE See historical trend | 45.08 (Average PE) |
P/B See historical trend | 6.76 (High P/B) |
Face Value | 10.00 |
Mkt Cap (Rs. Cr.) | 42,537 |
Dividend Yield | 0.00 |
20D Avg Volume | 1,270,938 |
20D Avg Delivery(%) | 58.91 |
Sector PE | 64.45 |
Book Value Per Share | 64.79 |
*Delayed by 20 seconds.
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
Days | |
---|---|
5 | - - |
10 | - - |
20 | - - |
50 | - - |
100 | - - |
200 | - - |
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
Days |
---|
Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
---|---|---|---|---|---|---|---|
Classic | - - | - - | - - | - - | - - | - - | - - |
Fibonacci | - - | - - | - - | - - | - - | - - | - - |
Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
R1 | - - | Pivot - - |
S1 | - - |
R2 | - - | S2 | - - | |
R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
Days |
---|
1 Week | --% | |
1 Month | --% | |
3 Months | --% | |
YTD | --% | |
1 Year | --% | |
3 Years | --% |
Buy Max Healthcare Institute; target of Rs 500: Prabhudas Lilladher Nov 03 2022 08:11 PM
Global Health IPO: Play on regional healthcare demand, subscribe for long term Nov 03 2022 10:11 AM
Max Healthcare Consolidated September 2022 Net Sales at Rs 1,137.12 crore, up 11.67% Y-o-Y Nov 01 2022 11:11 PM
Max Healthcare Standalone September 2022 Net Sales at Rs 474.14 crore, up 5.38% Y-o-Y Nov 01 2022 10:11 PM
Qty 699791 | Price 445.1 | % Traded 0.07 |
Qty 699791 | Price 445.1 | % Traded 0.07 |
Qty 699791 | Price 464.45 | % Traded 0.07 |
Qty 699791 | Price 464.45 | % Traded 0.07 |
Qty 376488 | Price 411.55 | % Traded 0.04 |
Qty 267293 | Price 411.55 | % Traded 0.03 |
Qty 376488 | Price 411.55 | % Traded 0.04 |
Qty 267293 | Price 411.55 | % Traded 0.03 |
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Qty 51948594 | Price 353 | % Traded 5.36 |
Qty 43751218 | Price 353 | % Traded 4.51 |
Qty 26549556 | Price 353 | % Traded 2.74 |
Qty 21630000 | Price 353 | % Traded 2.23 |
Qty 10605621 | Price 353 | % Traded 1.09 |
Qty 10546540 | Price 353 | % Traded 1.09 |
Qty 8041075 | Price 353 | % Traded 0.83 |
Qty 8041075 | Price 353 | % Traded 0.83 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
Qty 6874447 | Price 0 | % Traded 0.71 | Post Tnx Hold. 0% |
Qty 6874447 | Price 0 | % Traded 0.71 | Post Tnx Hold. 23.8% |
Qty 260196762 | Price 353.03 | % Traded 26.83 | Post Tnx Hold. 0.71% |
Qty 95143 | Price 342.55 | % Traded 0.01 | Post Tnx Hold. 0.01% |
Qty 17000 | Price 399.95 | % Traded 0.00 | Post Tnx Hold. 0% |
Qty 13000 | Price 405 | % Traded 0.00 | Post Tnx Hold. 0.01% |
*Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015
Qty 3895200 | Price 0 | % Traded 0.40 | Post Tnx Hold. 5.18% |
Qty 62495134 | Price 0 | % Traded 6.45 | Post Tnx Hold. 7.85% |
Qty 65381218 | Price 0 | % Traded 6.74 | Post Tnx Hold. 6.74% |
Qty 0 | Price 0 | % Traded 0.00 | Post Tnx Hold. 0% |
Qty 30863440 | Price 0 | % Traded 3.18 | Post Tnx Hold. 6.92% |
Qty 260196762 | Price 0 | % Traded 26.83 | Post Tnx Hold. 0.7% |
*Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Date | Agenda |
---|
Ex-Date | Type | Dividend (Rs) |
---|
Announcement Date | Ex-Bonus | Ratio |
---|
Ex-Split | Old FV | New FV |
---|
Ex-Right | Ratio | Premium |
---|
Date | Agenda |
---|
Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
---|---|---|---|---|---|---|---|---|---|---|
Max Healthcare | 438.15 | 0.82 | 42,537.16 | 45.08 | 6.76 | 9.63 | 18.58 | 605 | 3,931 | 0.12 |
Apollo Hospital | 4,224.35 | -1.87 | 60,739.67 | 72.35 | 10.30 | 18.77 | -5.83 | 1,101 | 14,662 | 0.47 |
Fortis Health | 277.90 | -1.42 | 20,980.29 | 41.05 | 2.99 | 8.98 | 2.53 | 765 | 5,717 | 0.16 |
Dr Lal PathLab | 2,069.55 | -2.44 | 17,250.50 | 69.56 | 11.18 | 22.86 | -30.20 | 350 | 2,087 | 0.23 |
Narayana Hruda | 724.15 | -0.39 | 14,798.79 | 33.20 | 9.94 | 22.96 | 11.39 | 350 | 3,701 | 0.37 |
Your feedback matters! Tell us what we got right and what we didn’t? Click here>